- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05012891
Gait Analysis Using OneStep Smartphone Application
Gait Analysis in Patients Undergoing Rehabilitation Due to Lower Extremity Disability or Chronic Pain, Using OneStep Smartphone Application.
Study Overview
Status
Intervention / Treatment
Detailed Description
Background:
Patient adherence is a crucial determinant of the rehabilitation process. After injury or surgery, many patients are given specific exercises to conduct unsupervised on their own to aid their recovery. Evidence suggests that noncompliance with the prescribed exercise regime is associated with poor rehabilitation outcomes. OneStep technology is a smartphone application (App), which uses smartphone sensors to provide ongoing gait diagnostics.
Study Objectives:
- To analyze gait-related parameters collected via the OneStep App in patients with lower extremity disability or chronic pain over a 4-week follow-up period during in-hospital physiotherapy sessions, self-exercises at home, and other daily activities,
- To objectively assess the patients' adherence and compliance with the prescribed rehabilitation regime. For the purposes of this research, adherence refers to the quantity and frequency of completed home exercises, while compliance refers to the quality of meeting the physiotherapists' walking-related recommendations.
- To assess gait parameters measured simultaneously on both feet, during standard walking-related tests, (performed under similar conditions on days 1, 14, 28, while using the OneStep App), for between and within-subject comparison.
- To compare between patients' subjective self-reports on performed physiotherapy workouts at home, the physiotherapists' own subjective assessments on their patients' adherence and compliance, and the objective data collected using the OneStep App
Methods:
Fifty consecutive patients with lower-extremity disability or pain, will be using the One-Step App, downloaded to their personal smartphones, in parallel with the usual rehabilitation treatments, during a one-month period. The study participants will be asked to carry the smartphone with the preinstalled app on them at all times, specifically on their injured foot.
All participants will also be required to undertake standard walking tests at the study initiation day (day 1) and on days 14 and 28 under similar conditions for between and within-subject comparison. Only during these tests will the subjects be using two smartphones preinstalled with the OneStep App, one attached to each leg, for a more accurate gait symmetry assessment.
During these 3 sessions, the study participants, as well as their physiotherapists, will be asked to fill in the study questionnaires.
Hypothesis:
Data collected using the OneStep App will allow an accurate and informative follow-up on patients' adherence and compliance with the rehabilitation regime and assist the physiotherapists in improving the efficacy of the rehabilitation process.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Tel Aviv, Israel
- Reuth Rehabilitation Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with a lower-extremity disability or chronic pain (unilateral or bilateral).
(Chronic pain was defined as pain lasting more than 3 months)
Description
Inclusion Criteria:
- Men and women aged 18 to 65 years old.
- Able to walk independently or with assistance (human/walking aids).
- Able to speak and read fluently in Hebrew.
- Admitted for rehabilitation at a rehabilitation hospital day-care center following lower-extremity disability or chronic pain (unilateral or bilateral).
- Have undergone at least 4 weeks of rehabilitation, but require an additional (at least one month long) rehabilitation course.
- Subjects must be willing to use their own smartphone device to install the OneStep application for study procedures and to comply with the study protocol.
- The subjects' smartphone has to be compatible with the OneStep app hardware requirements.
Exclusion Criteria:
- Subject unable to step on the sore foot.
- Subject unfit to participate in the study based on the judgment of the study principal investigator.
- Subjects who are permanently wheelchair-bound.
- Subjects with known pregnancy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study Population
Fifty (n=50) consecutive patients with lower-extremity disability or chronic pain (unilateral or bilateral), undergoing a rehabilitation course in a Day-Care Center setting.
|
OneStep technology is a smartphone application (app) utilizing smartphone sensors to provide ongoing gait diagnostics. The eligible study participants will be asked to download and install the app on their own smartphones and carry the smartphone in their front pants pocket at all times. The app will collect the required gait parameters but, will not present them (or any summary thereof) to the study participants or their physiotherapists, in order not to influence the rehabilitation plan. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking Distance (General Gait Parameter)
Time Frame: One month of follow-up
|
The daily walking distance (in meters) as measured by the OneStep App
|
One month of follow-up
|
Walking Time (General Gait Parameter)
Time Frame: One month of follow-up
|
The daily walking time (in minutes) as measured by the OneStep App
|
One month of follow-up
|
Step Count (General Gait Parameter)
Time Frame: One month of follow-up
|
The daily step count (number of steps) as measured by the OneStep App
|
One month of follow-up
|
Step Time (Leg Specific Parameter)
Time Frame: One month of follow-up
|
The average daily step time (in seconds) as measured by the OneStep App
|
One month of follow-up
|
Motion of the Hip Joint (Leg Specific Parameter)
Time Frame: One month of follow-up
|
The daily range of hip joint motion (in degrees) as measured by the OneStep App while walking.
|
One month of follow-up
|
Patients' Adherence with the Rehabilitation Regime
Time Frame: One month of follow-up
|
The patients' adherence with the rehabilitation regime refers to the quantity and frequency of completed home exercises, converted into an adherence score.
Patients' self-reports and physiotherapists' own assessments on patients' adherence will be collected using newly developed questionnaires, while the objective data on patients' adherence will be collected using the OneStep App.
|
One month of follow-up
|
Patients' Compliance with the Rehabilitation Regime
Time Frame: One month of follow-up
|
The patients' compliance with the rehabilitation regime refers to the quality of meeting the physiotherapists' walking-related recommendations, converted into a Compliance score.
Patients' self-reports and physiotherapists' own assessments on patients' compliance will be collected using newly developed questionnaires, while the objective data on patients' compliance will be collected using the OneStep App.
|
One month of follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-Minute Walk Test (6MWT)
Time Frame: Assessed at days 1, 14 and 28 of the follow-up period
|
It is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The distance (in meters) covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Each study subject will take this test 3 times: on days 1, 14, and 28 of the follow-up.
During these tests, the study participants will be using 2 phones, each preinstalled with the OneStep application and placed on each foot for simultaneous data collection, for within and between-subject comparison.
|
Assessed at days 1, 14 and 28 of the follow-up period
|
Timed Up and Go (TUG) Test
Time Frame: Assessed at days 1, 14 and 28 of the follow-up period
|
The test measures, in seconds, the time taken by an individual to stand up from a standard armchair walk a distance of 3 meters, turn, walk back to the chair, and sit down again.
The subjects are asked to wear their regular footwear and use their customary walking aids.
No physical assistance is given.
The subjects start the test with their back against the chair, their arms resting on the armrests, and their walking aid at hand.
They are instructed that on the word "go" they are to get up and walk at a comfortable and safe pace to a line on the floor 3 meters away, turn, return to the chair and sit down again.
Each subject walks through the test once before being timed in order to become familiar with the test.
Each subject will take this test 3 times (days 1, 14, and 28).
During these tests, the study participants will be using 2 phones, each preinstalled with the OneStep app and placed on each foot for simultaneous data collection, for within and between-subject comparison.
|
Assessed at days 1, 14 and 28 of the follow-up period
|
10-Meter Walk Test (10MWT)
Time Frame: Assessed at days 1, 14 and 28 of the follow-up period
|
The test is used to measure gait speed (in meters per second) of individuals with gait limitations.
A 10-meter straight course will be marked at its beginning and end with tape on the floor.
The study participant will be positioned 2 meters behind the first tape line.
The subject will then be instructed to walk at a comfortable rate until one passes the second tape line.
The timer is started when one crosses the first tape line and stopped when one crosses the second tape line.
The 2-meter distances before and after the course serve to minimize the effect of acceleration and deceleration.
The test is repeated 3 times and the average time is calculated.
Each study subject will take these tests on 3 occasions (days 1, 14, and 28).
During these tests, the study participants will be using 2 phones, each preinstalled with the OneStep application and placed on each foot for simultaneous data collection, for within and between-subject comparison.
|
Assessed at days 1, 14 and 28 of the follow-up period
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Pain Inventory (BPI)
Time Frame: Assessed at days 1, 14 and 28 of the follow-up period
|
The Brief Pain Inventory (BPI) is a multidimensional measurement tool, which contains a figure of the body on which patients can mark their painful sites.
The 4-item BPI Pain Severity Subscale is used to measure overall pain: at its worst, at its least, on average (all - over the last 24 hours) and at present, using a 0-10 numeric rating scale, where 0 indicates no pain and 10 corresponds to "severe or excruciating pain as bad as you can imagine".
The BPI has seven Numeric Rating Scales (NRS) that show how the pain interferes with function, mood, and enjoyment.
|
Assessed at days 1, 14 and 28 of the follow-up period
|
Lower Extremity Functional Scale (LEFS)
Time Frame: Assessed at days 1, 14 and 28 of the follow-up period
|
The LEFS is a 20-item self-report measure of physical function.
Each item is rated on a five-point scale (0-4), with lower scores representing greater difficulty.
Total scores can range from 0 to 80. Function is defined as follows: extreme difficulty or unable to perform activity (0-19 points), quite a bit of difficulty (20-39 points), moderate difficulty (40-59 points), a little bit of difficulty (60-79 points), and no difficulty (80 points).
|
Assessed at days 1, 14 and 28 of the follow-up period
|
ABC Confidence Scale
Time Frame: Assessed at days 1 and 28 of the follow-up period
|
Self administered 16 question assessment in which subjects are instructed to answer each question with a percentage of confidence that they will not fall while performing a given task from 0%-100%, with 0% being "not confident" and 100% being "confident".
Scores 80% or higher indicate a high level of physical functioning, 50-80% indicate a moderate level of physical functioning and scores less than 50% indicate a low level of physical functioning.
|
Assessed at days 1 and 28 of the follow-up period
|
Video Documentation
Time Frame: Recorded on days 1, 14 and 28 of the follow-up period
|
Subjects will be videotaped during their performance in the Six Minute Walk Test, Ten Meter Walk Test and Timed Up and Go Test to visually assess and document any changes in gait parameters, from baseline measurements.
The videotaping procedures will focus only on the subject's lower extremities.
|
Recorded on days 1, 14 and 28 of the follow-up period
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dana Gefen Doron, MD, Reuth Rehabilitation Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0008-20-RRH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain of Left Foot (Finding)
-
Reuth Rehabilitation HospitalActive, not recruitingChronic Pain of Left Foot (Finding) | Chronic Pain of Right Foot (Finding)Israel
-
Tetra Bio-PharmaTerminatedCancer | Chronic Pain Due to Malignancy (Finding)Canada
-
University of VirginiaNot yet recruitingPlantar Fascitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Plantar Fasciitis of Both Feet | Plantar Fasciitis of Right Foot | Plantar Fasciitis of Left FootUnited States
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
National and Kapodistrian University of AthensTerminatedDiabetic Foot | Chronic Diabetic Foot Ulcer of Right Foot | Neuropathic Foot Ulcer | Chronic Diabetic Ulcer of Left Foot (Diagnosis)Greece
-
Medipol UniversityRecruitingChronic Pain | Chronic Instability of Joint | Ankle Inversion Sprain | Athlete FootTurkey
-
Talita Cumi Ltd.Aetrex Worldwide IncCompleted
-
University of ArizonaRecruitingBreast Cancer | Chronic Pain Due to Malignancy (Finding)United States
-
University of the PunjabHigher Education Commission (Pakistan); Centre of Excellence in Molecular Biology... and other collaboratorsRecruitingDiabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetes Complications | Diabetic Foot Ulcer | Diabetic Foot Infection | Diabetic Foot Ulcer Neuropathic | Foot Ulcer Due to Type 1 Diabetes Mellitus | Foot Ulcer Due to Type 2 Diabetes Mellitus | Chronic Diabetic Ulcer of Left Foot | Chronic Diabetic Foot...Pakistan
-
Northern Orthopaedic Division, DenmarkCompleted
Clinical Trials on OneStep Smartphone Application
-
Reuth Rehabilitation HospitalActive, not recruitingChronic Pain of Left Foot (Finding) | Chronic Pain of Right Foot (Finding)Israel
-
Jordan University of Science and TechnologyNot yet recruitingUrinary IncontinenceJordan
-
Kibi International UniversityCompleted
-
University Hospital, MontpellierCompleted
-
Gunma UniversityCompletedSubthreshold DepressionJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMalignant Solid Neoplasm | Sarcoma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Central Nervous System NeoplasmUnited States
-
University Hospital, GrenobleRecruitingRaynaud PhenomenonFrance
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences, Fuwai HospitalCompletedCoronary Artery Disease | Diabetes Mellitus | Coronary Artery BypassChina
-
Jessa HospitalCompleted
-
Kibi International UniversityCompletedSubthreshold DepressionJapan